Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 13/04/2010
PIL Ultiva Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/04/2010 and displayed until Current
Reasons for adding or updating:
  • Change to information for healthcare professionals
  • Change to side-effects
Updated on 30/04/2009 and displayed until 13/04/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to date of revision
Updated on 03/06/2008 and displayed until 30/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 16/07/2007 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 30/04/2004 and displayed until 16/07/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  remifentanil hydrochloride